 Article
Feeds
|
FDA Nominee Announced in Wake of Congressional Concerns Over Proposed Fiscal Year 2007 Budget for Generic Programs and Growing Controversy Over Plan B Contraceptive |
March 3, 2007
Previously published on Spring 2006
During recent Congressional budget hearings, members of Congress expressed concern over the proposed cuts on the part of the U.S. Food and Drug Administration (FDA) to generic drug programs and the related backlog of more than 800 generic drug applications.
|
The views expressed in this article are solely the views of the author and not Martindale-Hubbell. This article is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance. |
|
|
RSS | Blogs | Site Map | Contact Us